Ignite Creation Date:
2024-05-06 @ 1:42 PM
Last Modification Date:
2024-10-26 @ 1:19 PM
Study NCT ID:
NCT04105959
Status:
COMPLETED
Last Update Posted:
2020-06-29
First Post:
2019-09-23
Brief Title:
A Study to Investigate the Effects of RIST4721 on the Inflammatory Response in Healthy Male Subjects Using a Blister Model
Sponsor:
Aristea Therapeutics Inc
Organization:
Aristea Therapeutics Inc
Study Overview
Official Title:
A Randomised Single-Blind Placebo-Controlled Crossover Study to Investigate the Effects of RIST4721 a Novel CXCR2 Inhibitor on the Inflammatory Response in Healthy Male Subjects Using a Standardized Blister Model
Status:
COMPLETED
Status Verified Date:
2020-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A Randomised Single-Blind Placebo-Controlled Crossover Study to Investigate the Effects of RIST4721 a Novel CXCR2 Inhibitor on the Inflammatory Response in Healthy Male Subjects Using a Standardized Blister Model
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None